Must Reads

New Report: Lance Armstrong 'Discussed Admission Of Guilt'

USA Today sports columnist Christine Brennan writes that:

"Lance Armstrong and U.S. Anti-Doping CEO Travis Tygart met for more than an hour in early to mid-December to discuss the possibility of a public admission that the banned cyclist used performance-enhancing drugs and blood transfusions during his long career, a person with knowledge of the meeting said Wednesday morning."

That follows an earlier story from The New York Times, which reported that Armstrong "has told associates and antidoping officials that he is considering publicly admitting that he used banned performance-enhancing drugs and blood transfusions during his cycling career, according to several people with direct knowledge of the situation."

Lance Armstrong in 2010. i i

hide captionLance Armstrong in 2010.

Timothy A. Clary /AFP/Getty Images
Lance Armstrong in 2010.

Lance Armstrong in 2010.

Timothy A. Clary /AFP/Getty Images

Meanwhile, on tonight's premiere of 60 Minutes Sports, Tygart tells CBS News' Scott Pelley that Armstrong once tried "to 'donate' about a quarter of a million dollars to the U.S. Anti-Doping Agency, a gesture that 'stunned' " the USADA CEO."

There's also word today that Oprah Winfrey says she's going to broadcast a "no-holds-barred interview" with Armstrong on Jan. 17. It will be on the Oprah Winfrey Network at 9 p.m. ET, and streamed live on Oprah.com.

Armstrong has always denied he cheated during his cycling career. Last August, though, he said he would stop fighting such allegations. He's been stripped of his seven Tour de France victories.

Tygart told All Things Considered last August that its investigation revealed that Armstrong and his USPS professional cycling team was running "one of the most sophisticated drug conspiracies we've ever seen."

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: